Adverum biotechnologies reports inducement grants under nasdaq listing rule 5635(c)(4)

Redwood city, calif., dec. 06, 2024 (globe newswire) -- adverum biotechnologies, inc. (nasdaq: advm) today announced that on december 4, 2024, the compensation committee of adverum's board of directors granted inducement awards consisting of non-qualified stock options to purchase 68,640 shares of common stock and restricted stock units (rsus) for 34,920 shares of common stock to 13 new employees under adverum's 2017 inducement plan. the compensation committee of adverum's board of directors approved the awards as an inducement material to the new employees' employment in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking